Insider buying last 90 days
No open-market insider purchases were filed for ADUS in the last 90 days.
From Form 4 filings, dated to when each was filed.
Oct 12 close
Addus HomeCare closed at $115.48 on 12 October 2026, +1% on the day. The price sits between the 50-day ($116.47) and 200-day ($105.69) moving averages, inside a 52-week range of $87.95 to $124.44. The GekkoIndex reads 56, in the Neutral zone, down 4.9 points over five sessions. Gekko Fair Value is $127.01, so the price is 9.1% below it.
The next earnings report is due on 2 November 2026, 21 days away (before open). Over the last 8 reports the company beat the earnings estimate 7 times, with an average move of 4.3% across the report. Seasonally, the next 20 trading days from this point averaged +11% over the last 5 years, rising in 5 of them.
9 firms rate the stock: 6 buy, 2 hold and 1 sell, with a consensus target of $134.08. A typical daily move is about 2.4%, and a typical 20-day move about 5.4%. On the swing-trade checklist, 2 items read supportive and 1 reads as a headwind (earnings risk).
A plain summary of the figures as of the Oct 12, 2026 close.
Addus HomeCare scores 2 supportive, 2 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive2 mixed1 headwind
Averages disagree
Close $115.48 sits between the 50-day ($116.47) and 200-day ($105.69) averages, or the averages disagree.
See the chart56, Neutral
Reading 56 is in the Neutral zone.
See the GekkoIndex9.1% below
Price is 9.1% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 21 days
Reports on Nov 2, 2026, 21 days away — inside a typical 20-trading-day hold.
See earnings+11.0% on average
From this point in the calendar, the next 20 trading days averaged +11% over 5 years, rising in 5 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Addus HomeCare closed at $115.48 on Oct 12, 2026, +1.0% over the past year, inside a 52-week range of $87.95 to $124.44.
Use the left and right arrow keys to read daily values.
Put ADUS on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Addus HomeCare provides in-home support to people across the United States, with a focus on seniors, those managing chronic illness or disability, and individuals at risk of being hospitalized or placed in institutional care. The company is widely recognized for its personal care services, which help clients with everyday tasks such as bathing, dressing, eating, taking medication, preparing meals, housekeeping, and getting to appointments.
Beyond personal care, Addus HomeCare operates through two additional segments. Its hospice arm offers nursing, social work, spiritual care, homemaking help, and grief support to terminally ill patients and their families, while its home health segment supplies skilled nursing and physical, occupational, and speech therapy to those recovering from illness or a hospital stay. Customers span government bodies at the federal, state, and local level, managed care organizations, commercial insurers, and individuals who pay privately.
Founded in 1979 and headquartered in Frisco, Texas, Addus HomeCare operates a network of offices spread across numerous states nationwide. Its shares trade on the NASDAQ under the ticker ADUS.
Addus HomeCare’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 56, in the Neutral zone, down 4.9 points over five sessions.
Down 4.9 points over five sessions, from the Accumulation zone.
Reading for Oct 12, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 25 | −2.4% | −3.8% | ||
| Accumulation | 223 | +0.8% | +2.1% | ||
| Neutral (current zone) | 406 | +0.1% | +0.5% | ||
| Distribution | 23 | +1.3% | +6.2% | ||
| Selling | 5 | Too few readings yet | |||
Average ADUS share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Addus HomeCare trades 9.1% below Gekko Fair Value of $127.01, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Addus HomeCare shares are worth, recalculated every trading day.
$127.01
Gekko Fair Value, Oct 10, 2026
9.1% Undervalued
At the end of Aug 2026 the price was 11.8% below the estimate.
No open-market insider purchases were filed for Addus HomeCare, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for ADUS in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in ADUS were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
1of the funds Gekko tracks holds ADUS.
Addus HomeCare reports on Nov 2, 2026, before the open (21 days away), and beat the EPS estimate in 7 of its last 8 reports.
Nov 2, 2026
Expected before the open, 21 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Mar 2, 2026 | $1.77 est $1.72 | — | −0.2% |
| Nov 3, 2025 | $1.56 est $1.53 | $362.3M est $372.9M | −4.0% |
| Aug 5, 2025 | $1.20 est $1.47 | $349.4M est $344.8M | +7.5% |
| Jun 12, 2025 | $1.16 est $1.09 | — | +0.1% |
| Feb 24, 2025 | $1.38 est $1.36 | $297.1M est $291.0M | −10.7% |
| Nov 4, 2024 | $1.30 est $1.28 | $289.8M est $278.4M | −1.7% |
| Aug 5, 2024 | $1.35 est $1.21 | $286.9M est $285.0M | +3.5% |
| May 6, 2024 | $1.21 est $1.09 | $280.7M est $284.4M | +6.5% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Addus HomeCare is $134.08, +16.1% from the last close, from 9 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 9 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 7 | Barclays | $96 | −16.9% |
| Sep 28 | Raymond James | $137 | +18.6% |
| Sep 15 | Truist Financial | — | — |
| Sep 14 | Bank of America Securities | $125 | +8.2% |
| Sep 14 | William Blair | — | — |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Oct 10, Addus HomeCare averaged +11.0% across the last 5 years, rising in 5 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +3.7% | 5 of 5 |
| Next 10 trading days | +5.1% | 4 of 5 |
| Next 15 trading days | +6.1% | 3 of 5 |
| Next 20 trading days | +11.0% | 5 of 5 |
| Next 30 trading days | +9.0% | 3 of 5 |
For scale, ADUS’s typical 20-trading-day move in either direction is about 5.4%.
Addus HomeCare’s market cap is $2.16B, with a P/E ratio of 20 and revenue of $1.48B over the last twelve months.
Coverage of Addus HomeCare this week reads positive: 3 positive, 0 neutral and 2 negative headlines.
Addus HomeCare’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| LHLabcorp | Neutral | 2.5% below |
| GHGuardant Health | Accumulation | 10.0% below |
| SOLVSolventum | Accumulation | 20.5% below |
| BTSGBrightSpring Health Services | Neutral | 2.8% above |
| EHCEncompass Health | Neutral | 7.3% above |
| DVADaVita | Neutral | 14.6% below |
A peer links to its own page where one exists.
Addus HomeCare’s market cap is $2.16B at the Oct 12, 2026 close of $115.48, with 18.66M shares outstanding. The shares trade on a P/E ratio of 20.
The consensus analyst 12-month price target for Addus HomeCare is $134.08, +16.1% from the last close. Of the 9 firms that rated the stock in the last 90 days, 6 rate it a buy, 2 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Addus HomeCare is undervalued: the Oct 12, 2026 close of $115.48 is 9.1% below Gekko Fair Value of $127.01. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Addus HomeCare is expected to report on Nov 2, 2026, before the market opens (21 days away). Analysts expect earnings of $1.79 per share on revenue of $388.7M. Addus HomeCare beat the earnings estimate in 7 of its last 8 reports, moving 4.3% on average across the report.
Addus HomeCare’s 52-week high is $124.44 and its 52-week low is $87.95; it closed at $115.48 on Oct 12, 2026, +1.0% over the past year. Over the last five years the shares peaked at $136.72 on Jan 22, 2025.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (fair value and seasonality), 2 as mixed (trend and gekkoindex) and 1 as a headwind (earnings risk). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.